Lennox-gastaut Syndrome
📧 Sign up to get email alerts when something new happens for Lennox-gastaut Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine [Phase 3]
Phase 3 trial evaluating soticlestat in Dravet syndrome or Lennox-Gastaut syndrome patients with prior fenfluramine exposure was terminated;…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Intermediate-Size Expanded Access Protocol (EAP) for LP352
Update on Longboard Pharmaceuticals' expanded access protocol for LP352, indicating availability for patients with Dravet syndrome, Lennox-G…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating cannabidiol delivered via the A-Synaptic GT4 transdermal system for …
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies [Phase 1, Phase 2]
Clinical trial update indicates LP352 has completed Phase 1/2 studies in developmental and epileptic encephalopathies. The program covers Dr…
-
CLINICAL_TRIALS withdrawal · 2024-10-03Clinical Trial Update: A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in Portugal
A Takeda-sponsored clinical trial investigating Dravet syndrome and Lennox-Gastaut syndrome in children, teenagers and adults in Portugal ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-24FDA Approved: FELBAMATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for felbamate from Amneal Pharmaceuticals of New York LLC, expanding the existing approval.
-
FDA approval · 2024-09-24FDA Approved: CLOBAZAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Ascend Laboratories, LLC.
-
FDA approval · 2024-09-16FDA Approved: CLOBAZAM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Amneal Pharmaceuticals NY LLC under the ANDA pathway.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome [Phase 3]
A Phase 3 study evaluating soticlestat as add-on therapy for Lennox-Gastaut syndrome across children, teenagers, and adults has completed, a…
-
FDA approval · 2024-07-29FDA Approved: CLOBAZAM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for CLOBAZAM (clobazam) submitted by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
A clinical trial comparing palliative surgery versus adding anti-seizure medications for Lennox-Gastaut syndrome to assess comparative effec…
-
FDA approval · 2024-07-15FDA Approved: CLOBAZAM — Supplemental Application (Novadoz Pharmaceuticals LLC)
The FDA approved a supplemental application for CLOBAZAM filed by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2024-06-10FDA Approved: CLOBAZAM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves a supplemental application for CLOBAZAM (clobazam) submitted by Camber Pharmaceuticals, Inc. The action updates the regulatory …
-
FDA approval · 2024-06-03FDA Approved: RUFINAMIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Rufinamide submitted by Ascend Laboratories, LLC.
-
FDA approval · 2024-05-24FDA Approved: CLOBAZAM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for CLOBAZAM filed by Bionpharma Inc., confirming an additional approval for this clobazam produ…
-
FDA label_change · 2024-05-15FDA Approved: CLOBAZAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Aurobindo Pharma Limited, updating the existing product through a suppl…
-
FDA approval · 2024-05-06FDA Approved: CLOBAZAM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for CLOBAZAM (clobazam) submitted by Micro Labs Limited.
-
FDA approval · 2024-03-12FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for ONFI (clonazepam) from Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2024-03-12FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for ONFI (clobazam) from Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2024-03-12FDA Approved: SYMPAZAN — Supplemental Application (Aquestive Therapeutics)
FDA approved a supplemental application for Sympazan (clobazam) submitted by Aquestive Therapeutics.
-
FDA approval · 2024-03-04FDA Approved: EPIDIOLEX — Supplemental Application (Jazz Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Epidiolex (cannabidiol) from Jazz Pharmaceuticals.
-
FDA approval · 2024-01-18FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited. The action updates the product labeling and may expa…
-
FDA approval · 2023-12-05FDA Approved: RUFINAMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic Rufinamide as an original application for adjunctive treatment of seizures associated with Lenn…
-
FDA approval · 2023-10-20FDA Approved: EPIDIOLEX — Supplemental Application (Jazz Pharmaceuticals, Inc.)
FDA approved a supplemental application for Epidiolex (cannabidiol) submitted by Jazz Pharmaceuticals, Inc. The action updates the labeling …
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy [Phase 2]
Phase 2 trial investigating add-on low-dose fenfluramine in Lennox-Gastaut epilepsy.